O'Shaughnessy Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,020
| Closed | -$242K | – | 2734 |
|
|
2025
Q4 | $242K | Buy |
+3,020
| New | +$203K | ﹤0.01% | 1890 |
|
|
2025
Q3 | – | Sell |
-2,749
| Closed | -$205K | – | 2600 |
|
|
2025
Q2 | $205K | Sell |
2,749
-714
| -21% | -$47.3K | ﹤0.01% | 1823 |
|
|
2025
Q1 | $220K | Buy |
3,463
+138
| +4% | +$9.39K | ﹤0.01% | 1734 |
|
|
2024
Q4 | $260K | Buy |
3,325
+3
| +0.1% | +$241 | ﹤0.01% | 1612 |
|
|
2024
Q3 | $250K | Sell |
3,322
-283
| -8% | -$22.9K | ﹤0.01% | 1565 |
|
|
2024
Q2 | $298K | Buy |
3,605
+298
| +9% | +$26.2K | ﹤0.01% | 1372 |
|
|
2024
Q1 | $282K | Sell |
3,307
-898
| -21% | -$70.5K | ﹤0.01% | 1343 |
|
|
2023
Q4 | $360K | Sell |
4,205
-1,841
| -30% | -$159K | ﹤0.01% | 1139 |
|
|
2023
Q3 | $542K | Sell |
6,046
-1,529
| -20% | -$137K | 0.01% | 907 |
|
|
2023
Q2 | $645K | Sell |
7,575
-210
| -3% | -$17.8K | 0.01% | 785 |
|
|
2023
Q1 | $644K | Sell |
7,785
-4
| -0.1% | -$324 | 0.01% | 781 |
|
|
2022
Q4 | $613K | Buy |
7,789
+3,097
| +66% | +$249K | 0.01% | 733 |
|
|
2022
Q3 | $347K | Buy |
+4,692
| New | +$337K | 0.01% | 874 |
|
|
2021
Q4 | – | Sell |
-263
| Closed | -$19K | – | 1751 |
|
|
2021
Q3 | $19K | Sell |
263
-122
| -32% | -$7.7K | ﹤0.01% | 1955 |
|
|
2021
Q2 | $26K | Sell |
385
-702
| -65% | -$49.7K | ﹤0.01% | 1766 |
|
|
2021
Q1 | $121K | Sell |
1,087
-20
| -2% | -$2.48K | ﹤0.01% | 1111 |
|
|
2020
Q4 | $131K | Buy |
1,107
+351
| +46% | +$37.8K | ﹤0.01% | 986 |
|
|
2020
Q3 | $66K | Sell |
756
-3,041
| -80% | -$266K | ﹤0.01% | 1020 |
|
|
2020
Q2 | $340K | Sell |
3,797
-1
| -0% | -$101 | 0.01% | 495 |
|
|
2020
Q1 | $380K | Sell |
3,798
-3,835
| -50% | -$416K | 0.01% | 339 |
|
|
2019
Q4 | $876K | Sell |
7,633
-11,077
| -59% | -$1.34M | 0.02% | 297 |
|
|
2019
Q3 | $2.36M | Sell |
18,710
-58,710
| -76% | -$7.45M | 0.06% | 169 |
|
|
2019
Q2 | $9.31M | Sell |
77,420
-14,976
| -16% | -$1.47M | 0.22% | 85 |
|
|
2019
Q1 | $8.07M | Sell |
92,396
-10,924
| -11% | -$993K | 0.19% | 96 |
|
|
2018
Q4 | $10.3M | Sell |
103,320
-2,234
| -2% | -$235K | 0.26% | 71 |
|
|
2018
Q3 | $12.1M | Buy |
105,554
+73,483
| +229% | +$7.61M | 0.25% | 76 |
|
|
2018
Q2 | $2.86M | Buy |
32,071
+15,699
| +96% | +$1.33M | 0.06% | 168 |
|
|
2018
Q1 | $1.2M | Buy |
16,372
+16,345
| +60,537% | +$1.12M | 0.03% | 229 |
|
|
2017
Q4 | $2K | Buy |
+27
| New | +$1.42K | ﹤0.01% | 867 |
|
Other funds holding HAE
RRAM
O'Shaughnessy Asset Management's HAE Position: Q1 2026 in Review
O'Shaughnessy Asset Management sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 3,020 shares — an estimated $242K sold.
O'Shaughnessy Asset Management first reported a position in HAE in Q4 2017 and held it in 29 quarters. The position peaked at $12.1M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- O'Shaughnessy Asset Management reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
- O'Shaughnessy Asset Management sold 3,020 Haemonetics shares in Q1 2026, an estimated $242K.
- O'Shaughnessy Asset Management first reported a position in Haemonetics in Q4 2017 and held it in 29 quarters.
- O'Shaughnessy Asset Management's Haemonetics position peaked at $12.1M in Q3 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.